Hereditary breast and ovarian cancer predisposition management for asymptomatic patient carrier of a BRCA mutation

被引：0
|
作者：
Bonfanti, Arianna [1 ]
Cordier, Christophe [1 ]
机构：
[1] Synlab, Lausanne, Switzerland
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2022年 / 30卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P22.002.A
引用
收藏
页码：560 / 560
页数：1
相关论文
共 50 条
  • [31] Breast Cancer Following Ovarian Cancer in BRCA Mutation Carriers
    Gangi, Alexandra
    Cass, Ilana
    Paik, Daniel
    Barmparas, Galinos
    Karlan, Beth
    Dang, Catherine
    Li, Andrew
    Walsh, Christine
    Rimel, Bobbie J.
    Amersi, Farin F.
    JAMA SURGERY, 2014, 149 (12) : 1306 - 1313
  • [32] Breast cancer after ovarian cancer in BRCA mutation carriers
    Nanez, A.
    Powell, C. B.
    Garcia, C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 256 - 256
  • [33] BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer
    Pristauz G.
    Geigl J.B.
    Petru E.
    Wiener Medizinische Wochenschrift, 2010, 160 (7-8) : 158 - 162
  • [34] A novel BRCA1 mutation in a patient with breast and ovarian cancer: A case report
    Salgado, Josefa
    Santisteban, Marta
    Gutierrez, Cristina
    Gil, Carmen
    Robles, Maitane
    Viedma, Adriana
    Patino-Garcia, Ana
    ONCOLOGY LETTERS, 2013, 6 (03) : 725 - 727
  • [35] Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer
    Felicio, Paula S.
    Grasel, Rebeca S.
    Campacci, Natalia
    de Paula, Andre E.
    Galvao, Henrique C. R.
    Torrezan, Giovana T.
    Sabato, Cristina S.
    Fernandes, Gabriela C.
    Souza, Cristiano P.
    Michelli, Rodrigo D.
    Andrade, Carlos E.
    De Figueiredo Barros, Bruna Duraes
    Matsushita, Marcus M.
    Revil, Timothee
    Ragoussis, Jiannis
    Couch, Fergus J.
    Hart, Steven N.
    Reis, Rui M.
    Melendez, Matias E.
    Tonin, Patricia N.
    Carraro, Dirce M.
    Palmero, Edenir, I
    HUMAN MUTATION, 2021, 42 (03) : 290 - 299
  • [36] PARP inhibitors for hereditary breast cancer with germline BRCA mutation
    Im, Seock-Ah
    ANNALS OF ONCOLOGY, 2022, 33 : S423 - S423
  • [37] VUS VARIANTS IN BRCA GENES OF HEREDITARY BREAST/OVARIAN CANCER
    Perez, M.
    Margarese, N.
    Calo, V.
    Bruno, L.
    La Paglia, L.
    Cimino, S.
    Corsini, L. R.
    Terrasi, M.
    Fanale, D.
    Amodeo, V.
    Insalaco, L.
    Napoli, L.
    Di Gaudio, F.
    Di Piazza, F.
    Miraglia, M. C.
    Bazan, V.
    Russo, A.
    CANCER TREATMENT REVIEWS, 2010, 36 : S118 - S119
  • [38] Management of the BRCA mutation carrier or high-risk patient
    Bordeleau, Louise J.
    Lipa, Joan E.
    Neligan, Peter C.
    CLINICS IN PLASTIC SURGERY, 2007, 34 (01) : 15 - +
  • [39] A novel BRCA1 mutation in an Iranian family with hereditary breast and ovarian cancer syndrome.
    Moslehi, R
    Kariminejad, MH
    Ghaffari, V
    Narod, S
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1166S - 1166S
  • [40] Impact of BRCA mutation test results in members of hereditary breast ovarian cancer (HBOC) families.
    Snyder, C
    Lynch, JA
    Karatoprakli, P
    Coronel, S
    Trowonou, A
    Metcalfe, K
    Narod, SA
    Gong, G
    Lynch, HT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 109S - 109S
12345